Publication Name	World Journal of Diabetes
Manuscript ID	64629
Country	Italy

Received	2021-02-28 21:00
Peer-Review Started	2021-02-28 21:11
To Make the First Decision
Return for Revision	2021-07-15 18:37
Revised	2021-09-14 21:52
Second Decision	2022-02-21 07:28
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-02-23 20:57
Articles in Press	2022-02-23 20:57
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-03-08 17:57
Publish the Manuscript Online	2022-03-15 14:23

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Review
Article Title	Markers of insulin resistance in Polycystic ovary syndrome women: An update
Manuscript Source	Invited Manuscript
All Author List	Chantal Anifa Amisi
ORCID	Author(s) ORCID Number Chantal Anifa Amisi http://orcid.org/0000-0001-5396-0302
Funding Agency and Grant Number
Corresponding Author	Chantal Anifa Amisi, MD, PhD, Doctor, Senior Researcher, Endocrinology and Diabetes Unit, Department of Medicine, Universita Campus Bio-medico di Rome, via alvaro del portillo 21, Rome 00128, Italy. chantalamisi@yahoo.fr
Key Words	Markers; Insulin resistance; Polycystic ovary syndrome; Emerging markers; Impaired glucose tolerance
Core Tip	Diagnosing insulin resistance in Polycystic ovary syndrome is of crucial importance for better management and prevention of complications. Seeking of an easy-to-detect surrogate marker of insulin resistance represents a promising approach for maximizing treatment outcomes. This review highlights markers of insulin resistance already used in women with Polycystic ovary syndrome, including new markers recently reported in literature, and establishes a new classification of them.
Publish Date	2022-03-15 14:23
Citation	Amisi CA. Markers of insulin resistance in Polycystic ovary syndrome women: An update. World J Diabetes 2022; 13(3): 129-149
URL	https://www.wjgnet.com/1948-9358/full/v13/i3/129.htm
DOI	https://dx.doi.org/10.4239/wjd.v13.i3.129

Full Article (PDF)	WJD-13-129.pdf
Full Article (Word)	WJD-13-129.docx
Manuscript File	64629_Auto_Edited.docx
Answering Reviewers	64629-Answering reviewers.pdf
Audio Core Tip	64629-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	64629-Conflict-of-interest statement.pdf
Copyright License Agreement	64629-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	64629-Language certificate.pdf
Peer-review Report	64629-Peer-review(s).pdf
Scientific Misconduct Check	64629-Bing-Liu M-1.png
Scientific Misconduct Check	64629-Bing-Wang LL-2.png
Scientific Editor Work List	64629-Scientific editor work list.pdf